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Abstract
Background: Helicobacter hepaticus colonizes the intestine and liver of mice causing hepatobiliary disorders such
as hepatitis and hepatocellular carcinoma, and has also been associated with inflammatory bowel disease in
children. In its habitat, H. hepaticus must encounter bile which has potent antibacterial properties. To elucidate
virulence and host-specific adaptation mechanisms of H. hepaticus modulated by human or porcine bile, a
proteomic study of its response to the two types of bile was performed employing two-dimensional gel
electrophoresis (2-DE) and mass spectrometry.
Results: The 2-DE and mass spectrometry analyses of the proteome revealed that 46 proteins of H. hepaticus were
differentially expressed in human bile, 18 up-regulated and 28 down-regulated. In the case of porcine bile, 32
proteins were differentially expressed of which 19 were up-regulated, and 13 were down-regulated. Functional
classifications revealed that identified proteins participated in various biological functions including stress response,
energy metabolism, membrane stability, motility, virulence and colonization. Selected genes were analyzed by RT-
PCR to provide internal validation for the proteomic data as well as provide insight into specific expressions of
motility, colonization and virulence genes of H. hepaticus in response to human or porcine bile.
Conclusions: Overall, the data suggested that bile is an important factor that determines virulence, host
adaptation, localization and colonization of specific niches within host environment.
Keywords: Bile, Bile acids, Hepaticus, Helicobacter, Proteome, Oxidative stress, Host adaptation, Virulence,
Colonization
Introduction
Helicobacter hepaticus belongs to the genus Helicobacter
whose best known specie is the human gastric carcino-
gen Helicobacter pylori. Members of the genus are
Gram-negative, microaerophilic bacillar bacteria that are
classified either as gastric or enterohepatic species
(EHS) depending on their target organs. H. hepaticus is
the prototype EHS and the most studied species of the
group. It was first isolated in 1992 from the liver speci-
men of laboratory mice suffering from chronic hepatic
inflammation and liver cancer [1], and it is now known
that the infection caused by the bacterium is widespread
among mouse colonies worldwide [2-4]. In humans, H.
hepaticus has been associated with hepatocellular carci-
noma (HCC), cholangiocarcinoma (CC) [5,6],
cholelithiasis [7], and inflammatory bowel disease
[4,8-10]. Experimental infection with the bacterium has
been used as a model of microbial tumor promotion in
the liver, colon and mammary glands [11-13], providing
ample opportunity to elucidate specific relationships of
this group of bacteria with the hosts.
The detection of H. hepaticus DNA in human bile
samples [9] of biliary disease patients and in specimens
of patients suffering from HCC and CC [5], provided
links between infection with the bacterium and hepato-
biliary diseases in humans. In mice suffering from differ-
ent hepatobiliary disorders, H. hepaticus is routinely
cultured from their colon and liver. However, in speci-
mens from patients with various hepatobiliary disorders
in which bacterial DNA had been detected, attempts to
culture the bacterium have largely been unsuccessful,
suggesting that factors in the host hepatobiliary environ-
ment play a significant role in determining the
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ogy of the bacterium.
Bile is an environmental factor present in the colon and
hepatobiliary tracts of higher animals with which H.
hepaticus and other intestinal bacteria must come in con-
tact in their hosts. Bile is a complex dietary secretion
composed of bile salts, lipids, proteins, ions, creatinine,
pigments such as bilirubin and biliverdin, etc.; accord-
ingly, the response of intestinal flora to bile has multiple
facets. Bile salts are the major component of bile and
have surface-active amphipathic properties, which can
disrupt the lipid bilayer of cell membranes, a property of
bile salts that confers antibacterial activity on bile. There
are differences in the antibacterial potency of different
bile acids: unconjugated bile acids are more toxic than
conjugated bile acids, and the bactericidal effect of dihy-
droxyl bile acids is greater than that of the trihydroxyl
bile acids. The composition of bile acids in the bile vary
between vertebrate species; under physiological condi-
tions the predominant bile acids in fowl, mice and cattle
are chenodeoxycholic, muricholic and cholic acids
respectively [14,15]. The composition of bile acids in
human bile is made up of ca. 40% cholic acid, 40% che-
nodeoxycholic acid and 20% deoxycholic acid, with traces
of ursodeoxycholic acid and lithocholic acid [16]; while
the bile acid composition of porcine bile is ca. 30% glyco-
cholic acid, 40% taurocholic acid, 7% taurodeoxycholic
acid, 15% glycodeoxycholic acid and 5% hyodeoxycholic
acid. Porcine and bovine bile are the two commercially
available bile types as at the time of this study, and the
response of H. hepaticus to bovine bile has been investi-
gated [17]. In this study, the global responses of H.
hepaticus to human and porcine bile were compared
with the aim of elucidating specific bacterial-host adapta-
tion and virulence expression mechanisms.
Results and discussion
Growth inhibition and morphological changes of H.
hepaticus ATCC 51449 in the presence of human and
porcine bile
The growth of H. hepaticus in human or porcine bile was
tested. The bacterium was grown under a microaerobic
condition for 48 h in media supplemented with 0-0.5%
concentrations of human or porcine bile. Changes in bac-
terial morphology from normal helical-bacillar to spheri-
cal-coccoid cells were observed in both human and
porcine bile that were similar to those observed in bovine
bile by H. hepaticus [17] and H. pylori [18]. The morpho-
logical changes were observed in greater number of bac-
teria at lower concentrations of human bile than porcine
bile, for example, at 0.1% bile concentration, approxi-
mately 68% of the bacterial cell population in human bile
had become coccoid compared to the 11% of bacteria in
the porcine bile (Figure 1).
The growth of bacteria depended on the type of bile
as well as on bile concentrations (Figure 2). H. hepaticus
exhibited higher susceptibility to human bile than to
porcine bile. At 0.025% human bile concentration, there
was a reduction of viable cells by ca.1 - l o gu n i tr e p r e -
senting half of the bacterial density relative to the con-
trol cultures without bile (Figure 2a). In contrast, a
much higher porcine bile concentration of 0.25% was
required to observe a similar ca.1 - l o gr e d u c t i o ni nt h e
bacterial viable counts (Figure 2b). This represents a
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Figure 1 Change in morphology of H. hepaticus in the presence of human bile [A] and porcine bile [B]. In both types of bile, the
percentage of coccoid forms in the bacterial population was higher at high bile concentrations. Data and standard errors are from three
independent experiments.
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Page 2 of 16ten-fold higher toxicity of the human bile to H. hepati-
cus. The observed difference in susceptibility could be
attributed to differences in the physico-chemical proper-
ties of the bile acids present in both types of bile.
Human bile is composed predominantly of unconju-
gated primary bile acids, cholic and chenodeoxycholic
acids [19], whereas in porcine bile predominantly conju-
gated secondary bile acids, taurocholic and glycocholic
acids are present. The effects of porcine bile on H.
hepaticus growth were similar to those of bovine bile
[17]: no viable cells were found at approximately 0.5%
concentration of both types of bile although the
decrease in viability was faster initially in bovine bile.
Like porcine bile, bovine bile is also predominantly
composed of conjugated secondary bile acids (40%
taurocholic acid and 20% glycocholic acid). Mouse is the
natural host of H. hepaticus,a n di t sb i l ei sm a d eu p
mostly of muricholic acid, a secondary bile acid, [20];
mouse bile could not be included in this study because
of the difficulty in obtaining it in sufficient quantity.
U n c o n j u g a t e dp r i m a r yb i l ea c i d sa r em o r et o x i ct h a n
conjugated secondary bile acids because the former can
flip-flop passively across the lipid bilayer of cell mem-
branes and enter the cells. In the cells, accumulated pri-
mary bile acids dissociate leading to reduction in internal
pH and dissipation of the transmembrane proton gradient
[21]. Therefore, in addition to their membrane damaging
effects, primary bile acids can cause inhibition of cell
growth by either intracellular acidification and/or trans-
membrane proton gradient dissipation. This could account
for the greater susceptibility of H. hepaticus to human bile
than to porcine or bovine bile, and may be a reason for
the inability to culture the bacterium from human samples
in which its DNA has been detected since the presence of
DNA would not be an indicator that culturable bacteria
are present. The antibacterial effects of bile could explain
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Figure 2 Growth of H. hepaticus in medium containing different concentrations of [a] human bile and [b] porcine bile. The controls
were cultures without bile [c]. Growth rate of H. hepaticus between 0 and 60 h in 0% bile (♦), 0.05% human bile (■), 0.1% human bile (▲), 0.1%
porcine bile (×), and 0.25% porcine bile (●). The data and standard errors are from three independent experiments.
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Page 3 of 16also the greater difficulty in culturing H. hepaticus from
liver than from intestinal specimens [22,23] in mice, since
in the former it would be present at higher concentration
and unconjugated primary bile acids are found in greater
proportion in the liver than in the intestine. Thus, the dif-
ference in the composition of bile acids in various organs
within the host could determine H. hepaticus colonization
of its niche as well as viability in laboratory cultures.
Measurement of growth rates of H. hepaticus in 0%,
0.05% and 0.1% human bile, and in 0.1% and 0.25% por-
cine bile showed exponential growth up until 48 h in
0% bile, 0.05% human bile and 0.1% porcine bile con-
centrations (Figure 2c). Thus, 0% bile (control condi-
tion), 0.05% human bile and 0.1% porcine bile (test
conditions) were chosen as the conditions to perform
the proteomic and transcriptomic studies.
Identification of proteins differentially expressed by H.
hepaticus in cultures with sub-lethal human or porcine
bile concentrations
Differential expression of proteins that could play var-
ious roles in the ability of H. hepaticus to adapt to
human or porcine bile was obtained employing 2D-
PAGE. Based on the data from previous [17] isoelectric
point and grand average hydropathy analyses indicating
that the majority of H. hepaticus proteins with isoelec-
tric points between 4 and 7 are cytosolic, the present
investigation focused on the expression of this set of
proteins in the presence of human and porcine bile con-
centrations of 0.05% and 0.1%, respectively. The protein
expression of cells grown in the absence of bile was
employed as control and compared to those of cells
grown separately in the two types of bile as test cultures.
The expression of proteins with differential spot intensi-
ties equal to or greater than 2-fold between cells grown
in test and control cultures are considered to be modu-
lated by the presence of bile; those protein spots were
subsequently analyzed by mass spectrometry after tryp-
sin digestion. Figure 3 shows 2D gels of cell protein
extracts of H. hepaticus g r o w ni nt h ea b s e n c eo ri nt h e
presence of 0.05% human bile or 0.1% porcine bile. Ana-
lyses of the proteomes revealed that 46 proteins were
differentially expressed in human bile, 18 up-regulated
and 28 down-regulated (Figure 3a, b). In cultures with
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Figure 3 2D-gels showing H. hepaticus cytosolic protein profile at pI 4-7. Proteins were extracted from bacterial cells grown at 0% Human
bile [a], 0.05% Human bile [b]; 0% Porcine bile [c], and 0.1% Porcine bile [d]. Differentially expressed protein spots are numbered on the gels,
orange characters indicate up-regulated spots while dark characters indicate down-regulated spots. Proteins in spots were identified by LC-MS/
MS and listed in Table 1.
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Page 4 of 16porcine bile, a total of 32 proteins were differentially
expressed of which 19 were up-regulated, and 13 were
down-regulated (Figure 3b, c).
The identities of the proteins differentially expressed
are listed in Table 1. Among these proteins were several
potential isoforms; these were proteins identified in
more than one protein spot. In the gels from human
bile/H. hepaticus co-cultures, potential isoforms of dihy-
dropicolinate reductase (DapA), GTP-binding protein
(YihK), ferredoxin oxidoreductase (PorA), aconitase
(AcnB), and flagella were identified. In the gels from
cultures with porcine bile, potential isoforms of ATP-
dependent CLP protease (ClpA) and AcnB were identi-
fied (Table 1). These findings suggested that various
proteins were posttranslationally modified and may
manifest adaptations to human and porcine bile stress.
Posttranslational protein modification has been reported
also in C. jejuni and Wolinella succinogenes cultures in
the presence of bile [24,25].
Functional classification of identified proteins
Functional analysis of proteins was done with the Kyoto
Encyclopedia of Genes and Genomes (KEGG) (http://
www.genome.jp/kegg/), the Database for Annotation,
Visualization and Integrated Discovery (DAVID 2.1)
(http://david.abcc.ncifcrf.gov/), and by comparison with
the published literature. The functions of identified pro-
teins are listed on Table 1.
Stress response
Evidence for the induction of oxidative stress response
in H. hepaticus by both human and porcine bile was
provided by the down-regulation of the TCA cycle
enzymes, AcnB and fumarase (FumC). In particular, the
down-regulation by both types of bile of AcnB, which in
t h eT C Ac y c l ei st h em o s ts e n s i t i v ee n z y m et or e a c t i v e
oxygen species (ROS) [26], supports this interpretation.
Many bactericidal antimicrobial agents are known to sti-
mulate production of hydroxyl radicals, which contri-
bute to cell death via a mechanism which includes
hyperactivation of the electron transport chain that sti-
mulates superoxide formation [27]. An increased con-
centration of this radical negatively affects iron-sulfur
clusters leading to the release of ferrous ions which
become available for oxidation by the Fenton reaction
with the generation of hydroxyl radicals capable of
damaging DNA and proteins [27]. The down-regulation
of AcnB and FumC may reflect a strategy to counteract
a similar toxicity mechanism induced by bile through
the reduced production of isocitrate and malate, meta-
bolites that feed electrons to the electron transport
chain. As a result, the activities of Fenton reactions will
be down-regulated and the generation of superoxide
radicals will decrease. The down-regulation of the typi-
cal oxygen scavangers, superoxide dismutase and
catalase, would reflect lower levels of superoxide anions
in the cell. Somewhat counterintuitive was the apparent
up-regulation in porcine bile of fumarate reductase,
which catalyzes the production of NADH and fumarate
from succinate and NAD
+; increased production of
NADH, which is utilized in the electron transport chain
would concomitantly lead to increased ROS production.
Perhaps this unexpected up-regulation of fumarate
reductase can arise from the bacterial response that may
be multiplexed, such as a strategy to up-regulate its
anaerobic respiration, in which the enzyme catalyzes the
final step of ATP synthesis with fumarate as the term-
inal electron acceptor [28]. This strategy would reduce
the levels of hydroxyl radicals generated from superox-
ide anions produced in aerobic respiration by increasing
anaerobic respiration in preference to aerobic respira-
tion. In response to bovine bile [17], down-regulation of
fumarate reductase together with other enzymes of TCA
suggested a strategy by the bacterium to reduce succi-
nate and other metabolites utilized in the electron trans-
port chain in order to minimize the effects of
superoxide radicals.
Likewise, the up-regulation of pyruvate:ferredoxin
reductase (PorA) in the presence of human bile could
show a strategy by the bacterium to minimize genera-
tion of ROS. PorA is a known NADPH:paraquat dia-
phorase (NADPH:PQ
2+), and participates in the control
of singlet oxygen production through the reduction of
PQ
2+ in the cell [29]. The down-regulation of acetyl-
CoA carboxylase and S-malonyltransferase, both of
which consecutively catalyze the conversion of Ac-CoA
to carboxyl carrier proteins, suggested the preservation
of Ac-CoA by the cells. This would preserve levels of
the coenzyme for the synthesis of citrate under condi-
tions in which the TCA enzymes are down-regulated.
Maintenance of adequate intracellular levels of citrate
may be required under conditions in which the TCA
cycle is down-regulated because it is a strong chelator of
ferric ions; the available citrate would contribute to the
sequestration of iron and thus to the reduction of
hydroxyl radical production. A similar control of hydro-
xyl radical levels was used in the response of H. hepati-
cus to bovine bile [17], suggesting that decreasing ROS
production is a response mechanism common to differ-
ent types of bile.
I nt h ep r e s e n c eo fp o r c i n eb i l e ,p r o t e c t i o na g a i n s t
hydroxyl radicals would be helped by the up-regulation
of TrxB1 and alkyl hydroperoxide reductase (TsaA). Up-
regulation of isocitrate dehydrogenase (Icd), which cata-
lyzes the oxidative decarboxylation of isocitrate to a-
ketoglutarate with concomitant production of NADH
could increase ROS production, but this can be com-
pensated by a-ketoglutarate, which interacts with oxyge-
nases to reduce molecular oxygen. In contrast, the
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Page 5 of 16Table 1 Proteins of H.hepaticus identified by LC-MS/MS whose expression was modulated by at least 2-fold in 0.05% human- or 0.1% porcine bile in the
growth media
Protein
a Fold change (±
SEM)
b
Gene Function
c Spot No. Matching score
d Coverage
(Peptide)
Observed/
Theoretical pI
e
Human Porcine Human Porcine Human Porcine Human Porcine Human Porcine
Amino acid metabolism
Dihydropicolinate reductase* 0.4 ±
0.01
3.5 ±
0.03
dapB Lysine biosynthesis 33 23 438 201 33(7) 26(12) 6.59/
6.24
5.7/6.24
Dihydropicolinate reductase* 0.1 ±
0.01
NI 32 - 430 - 44(19) - 6.50/
6.24
-
Glycine hydroxymethyltransferase 0.48 ±
0.1
2.5 ±
0.01
glyA Glycine hydroxymethyltransferase 18 17 330 278 26(6) 16(5) 6.57/
6.33
6.95/
6.33
Ketol-acid reductoisomerase 2.7 ±
0.3
NI ilvN Valine, leucine and isoleucine biosynthesis 27 - 916 49(14) - 6.59/
6.05
-
Threonyl-tRNA synthetase NI 4.0 ±
0.01
thrS Glycine, threonine and serine metabolism - 8 - 214 - 12(3) - 5.78/
6.06
2-isopropylmalate synthase NI 5.0 ±
0.01
leuA Valine, leucine and isoleucine biosynthesis - 9 - 148 - 26(12) - 5.78/
5.86
Phosphoglycerate dehydrogenase NI 0.4 ±
0.02
serA Serine family amino acid biosynthesis - 32 - 583 - 18(9) - 5.70/
5.84
Cellular metabolism
ATP-dependent CLP protease* NI 0.3 ±
0.01
clpA Endopeptidase activity - 3 - 941 - 41(19) - 5.92/
5.70
ATP-dependent CLP protease* NI 0.2 ±
0.06
- 4 - 1167 - 38(36) - 5.84/
5.70
Carbohydrate & energy metabolism
Aconitase* 0.25 ±
0.01
0.4 ±
0.01
acnB Citrate cycle, glyoxylate and dicarboxylate metabolism,
reductive carboxylate cycle
2 2 1237 784 48(28) 10(13) 6.65/
6.21
6.46/
6.21
Aconitase* 0.1 ±
0.03
0.4 ±
0.01
3 1 1491 665 29(20) 29(11) 6.54/
6.21
6.54/
6.21
Aconitase* 0.1 ±
0.01
NI 1 - 1488 - 43(14) - 6.76/
6.21
-
Aconitase* 0.2 ±
0.01
NI 4 - 866 - 34(12) - 6.46/
6.21
-
Alkyl hydroperoxide reductase NI 3.0 ±
0.01
tsaA Oxidative phosphorylation - 28 - 288 - 50(17) - 6.3/5.95
ATP synthase subunit A NI 4.0 ±
0.02
atpA - 12 - 891 - 43(19) - 5.7/5.69
ATP synthase subunit B NI 2.5 ±
0.1
atpB - 15 - 1509 - 53(12) - 5.12/
5.17
dDTP-glucose dehydratase 0.3 ±
0.01
NI rfbB Nucleotide sugar biosynthesis 23 - 549 - 31(5) - 5.57/
6.05
-
UDP-glucose 6-dehydrogenase 0.24 ±
0.06
NI kfiD Pentose and glucuronate interconversions; starch &
sucrose metabolism, nucleotide sugars metabolism
17 - 384 - 50(17) - 5.51/
5.27
-
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6Table 1 Proteins of H.hepaticus identified by LC-MS/MS whose expression was modulated by at least 2-fold in 0.05% human- or 0.1% porcine bile in the
growth media (Continued)
Ferredoxin oxidoreductase* 3.5 ±
0.02
NI porA Pyruvate metabolism 37 - 514 - 11(4) - 5.92/
5.91
-
Ferredoxin oxidoreductase* 2.5 ±
0.3
NI 22 - 900 - 35(20) - 6.38/
5.91
-
Fumarase 0.25 ±
0.1
0.4 ±
0.1
fumC Citrate cycle, reductive carboxylate cycle 30 13 566 725 47(8) 23(11) 6.62/
5.61
5.7/5.61
Fumarate reductase NI 6.0 ±
0.1
frdA Citrate cycle, oxidative phosphorylation - 6 - 734 - 38(36) - 5.7/7.23
Fructose-bisphosphate aldolase 2.8 ±
0.01
NI fba Glycolysis, gluconogenesis 19 - 975 - 50(13) - 6.59/
5.95
-
Isocitrate dehydrogenase NI 5.5 ±
0.02
icd Citrate cycle - 5 - 865 - 23(7) - 5.7/7.10
Malate dehydrogenase NI 2.0 ±
0.01
mdh Pyruvate metabolism - 21 - 710 - 42(9) - 6.89/
8.11
Phosphoglycerate kinase 2.5 ±
0.01
NI pgk Glycolysis, glyconogenesis 13 - 699 - 44(10) - 6.0/5.64 -
Rod shape determining protein 2.5 ±
0.2
NI mreB Cell shape determining protein 20 - 455 - 33(7) - 5.27/
5.16
-
Cellular oxygen metabolism & stress response
Catalase NI 0.1 ±
0.01
kat Superoxide metabolism - 10 - 715 - 27(5) - 5.7/6.75
Superoxide dismutase 0.1 ±
0.01
0.4 ±
0.3
sodF 16 27 137 411 13(2) 31(9) 6.49/
6.24
5.7/6.24
Thioredoxin reductase 0.3 ±
0.01
4.7 ±
0.03
trxB1 Oxygen & ROS metabolism 31 18 470 390 27 (12) 14(5) 5.41/
5.34
5.30/
5.34
Putative thioredoxin reductase
(HH1153)
0.2 ±
0.01
NI trxB2 24 - 381 - 16(5) - 5.95/
6.15
-
Chaperone & stress response
Hsp-70 (DnaK cofactor) 2.3 ±
0.03
NI grpE Heat shock protein 26 - 308 - 11(8) - 4.57/
4.62
-
Cpn60 NI 3.0 ±
0.01
groEL Chaperonin - 14 - 705 - 42(11) - 5.32/
5.19
Lipid metabolism
Acetyl-CoA caroxylase alpha
subunit
0.2 ±
0.01
NI accA Fatty acid biosynthesis 41 - 277 - 32(4) - 5.59/
5.47
-
7-Alpha-dehydroxysteroid
dehydrogenase
2.5 ±
0.01
NI fabG 46 - 629 - 23(11) - 6.19/
7.59
-
(3R)-hydroxymyristoyl ACP
dehydratase
NI 4.0 ±
0.01
fabZ - 7 - 356 - 28(6) - 6.95/
6.31
s-malonyltransferase 0.3 ±
0.01
NI fabD 15 - 311 - 31(5) - 5.49/
5.45
-
Motility & chemotaxis
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6Table 1 Proteins of H.hepaticus identified by LC-MS/MS whose expression was modulated by at least 2-fold in 0.05% human- or 0.1% porcine bile in the
growth media (Continued)
Flagellin* 2.5 ±
0.3
2.0 ±
0.01
flaB Flagella assembly 11 11 946 961 41(16) 60(11) 4.81/
6.38
4.57/
6.38
Flagellin* 0.3 ±
0.02
NI 10 - 833 - 13(10) - 4.95/
6.38
-
Flagellin* 0.4 ±
0.01
NI 9 - 699 - 26(9) - 4.89/
6.38
-
Flagellin assembly protein* 0.4 ±
0.01
NI fliH 35 - 474 - 31(5) - 4.86/
4.93
-
Flagellin assembly protein* 0.3 ±
0.01
NI 34 - 466 - 57(8) - 4.80/
4.93
-
Major flagellin subunit 2.4 ±
0.1
NI flaA 12 - 827 - 47(13) - 4.68/
5.56
-
Two-component system response
regulator
0.4 ±
0.01
NI ompR Two-component signal regulatory system 36 - 154 - 16(9) - 4.84/
5.63
-
Nucleotide metabolism
Adenylate kinase 0.2 ±
0.3
NI adk Purine metabolism 40 - 833 - 35(20) - 5.22/
5.09
-
DNA polymerase III subunit beta 3.0 ±
0.01
NI dnaN DNA metabolism 45 - 385 - 24(4) - 5.62/
5.33
-
Pathogenesis & virulence
Cytolethal distending toxin 0.1 ±
0.01
NI cdtC Virulence 44 - 444 - 20(9) - 4.81/
5.23
-
Urease subunit A NI 0.3 ±
0.03
ureA Urease activity, virulence - 24 - 393 - 52(8) - 5.32/
5.93
Protein translation & modification
Translation elongation factor Ts 3.2 ±
0.01
2.0 ±
0.1
ef-ts Protein translation 14 30 53 717 16(17) 36(12) 6.0/5.31 5.3/5.31
Translation elongation factor Tu 2.5 ±
0.01
2.0 ±
0.1
ef-tu 43 26 64 173 11(6) 15(13) 6.81/
4.93
5.49/
5.12
Signal transduction
GTP-binding protein* 3.5 ±
0.01
NI yihK Signal transduction 5 - 948 - 50(12) - 5.38/
5.26
-
GTP-binding protein* 3.0 ±
0.02
NI 6 - 706 - 42(11) - 5.43/
5.26
-
GTP-binding protein* 2.7 ±
0.01
NI 7 - 954 - 31(11) - 5.49/
5.26
-
GTP-binding protein* 3.5 ±
0.01
NI 8 - 638 - 37(9) - 5.54/
5.26
-
Putative ATP/GTP-binding protein 3.5 ±
0.02
NI mpr 38 - 700 - 26(17) - 6.08/
5.77
-
Amino-acid ABC transporter
periplasmic solute-binding protein
0.3 ±
0.1
NI pbpB ABC transporter protein 39 - 396 - 24(4) - 4.97/
5.17
-
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6Table 1 Proteins of H.hepaticus identified by LC-MS/MS whose expression was modulated by at least 2-fold in 0.05% human- or 0.1% porcine bile in the
growth media (Continued)
Putative ABC transporter protein 0.4 ±
0.01
NI yaeC 29 - 494 - 57(5) - 4.81/
5.16
-
Single-stranded DNA-binding
protein
NI 0.3 ±
0.1
ssb Single strand binding protein/primosomal replication - 25 - 238 - 27(4) - 5.38/
5.91
Putative protein function
HH1212 0.1 ±
0.03
NI hh1212 Hypothetical protein 25 - 349 - 14(5) - 6.34/
6.98
-
HH0952 0.3 ±
0.02
NI hh0952 28 - 267 - 9(3) - 4.27/
4.52
-
HH1514 0.4 ±
0.01
NI hh1514 42 - 286 - 17(9) - 5.97/
5.62
-
HH1023 0.2 ±
0.01
0.2 ±
0.01
hh1023 21 16 1312 410 43(21) 31(6) 5.86/
6.15
5.86/
6.15
HH1098 NI 4.0 ±
0.01
hh1098 - 31 - 156 - 10(2) - 5.7/5.71
HH1376 NI 0.3 ±
0.01
hh1376 - 19 - 121 - 11(3) - 5.89/
5.62
HH1034 NI 2.5 ±
0.1
hh1034 - 20 - 410 - 53(9) - 6.73/
6.22
HH1426 NI 0.4 ±
0.1
hh1426 - 22 - 348 - 28(6) - 6.49/
6.12
HH0243 NI 2.5 ±
0.01
hh0243 - 29 - 297 - 22(4) - 5.59/
5.63
aProteins were identified by LC-MS/MS and MASCOT searches of the NCBI nr database.
bProteins that were differentially expressed in the presence of 0.05% human bile or 0.1% porcine bile by at least 2-fold level of
expression. A fold change value of > 2 indicates up-regulation, while a value of < 0.5 indicates down-regulation.
cProteins were classified into functional categories based on KEGG pathway classification and DAVID
gene ontology, and by comparison with the published literature.
dProteins with peptides with matching scores of > 49 were considered to be identified.
ePredicted isoelectric point of each protein was obtained
from the Comprehensive Microbial Resource of the Institute of Genomic Research. NI = Not identified.
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6presence of human bile induced a down-regulation of
the thioredoxin reductases as well as a down-regulation
of the tsaA transcript, although TsaA was not found
among the regulated proteins of H. hepaticus in
response to human bile; this would hinder the ability of
the bacterial cells grown in human bile to control ROS.
Up-regulation of NAD(P) + -dependent oxidoreductase
7-alpha-hydroxysteroid dehydrogenase (FabG) would
add to the production of NADH or NADPH for cellular
biosynthetic reactions that may be required to compen-
sate for the down-regulation of the TCA cycle, but this
could result also in increased generation of hydroxyl
radicals. FabG was not identified among the regulated
proteins of H. hepaticus cells exposed to porcine bile.
Together, these observations suggested that larger
amounts of hydroxyl radicals would be generated in the
bacterial responses to human bile than to porcine bile,
and this will help to account for the higher susceptibility
of H. hepaticus to the former.
FabG was up-regulated in the presence of human bile,
in contrast to its down-regulation in cultures with
bovine bile [17] and non-regulation by porcine bile;
these differences may reflect an attempt to detoxify the
cholic and chenodeoxycholic acids found in higher pro-
portions in human bile than in porcine and bovine bile.
Hydroxylation renders bile more hydrophilic and conse-
quently less toxic [30]; and 7-dehydroxylation by the
enzyme FabG is restricted to few anaerobic intestinal
bacteria which represent a small fraction of the total
colonic flora [19]; modulation of this enzyme by H.
hepaticus in the presence of bile could be a mechanism
that the bacterium and possibly other EHS use in their
colonization of the enterohepatic habitat [31]. The
enzyme has been associated with tumour progression in
s u s c e p t i b l em i c e[ 3 2 ]a n dm a yc o n t r i b u t et ot u m o u r
formation.
The up-regulation of the chaperones GrpE and GroEL
in cultures with human and porcine bile, respectively,
indicated an increased need by H. hepaticus to maintain
proper folding of polypeptides in order to counteract the
damaging effects of bile acids on proteins and cell mem-
branes. In addition, H. hepaticus appeared to respond to
bile by undergoing important changes involving DNA
synthesis and repair, as well as protein translation and
transcription. This was manifested in the up-regulation
of DNA polymerase III subunit beta in human bile, and
would serve to improve error free DNA repair during
DNA replication, as well as in the up-regulation by both
types of bile of the elongation factors EF-Ts and EF-Tu,
that participate in protein translation, stress response
and DNA repair [33,34]. Up-regulation of EF-Ts and EF-
Tu has also been reported in the bile response of other
Campylobacterales [24,25], suggesting common bile
adaptation mechanisms of this bacterial group.
Energy balance
To survive the effects of bile requires energy, for exam-
ple to extrude bile acids out of the cytoplasm and to
maintain proper protein folding and homeostasis. The
down-regulation of TCA cycle reactions and decreased
electron supply to the electron transport chain by H.
hepaticus in the presence of bile would lower the energy
available for bile resistance. In response to porcine bile,
up-regulation of Icd and the ATP synthase subunits A
and B would serve to provide additional energy to the
bacterial cells. In contrast, ATP synthase was not found
among the regulated proteins of H. hepaticus in
response to human bile; also, the up-regulated phospho-
glycerate kinase and fructose-bisphosphate aldolase
involved in glycolysis cannot translate into increased
production of energy as H. hepaticus lacks pyruvate
kinase to catalyze the substrate-level phosphorylation
that uses ADP and phosphoenolpyruvate as substrates
downstream of glycolysis [35]. The lowered expression
of the ATP-dependent ABC transporters PbpB and
YaeC reflected the lower energy in the bacterium as a
consequence of the effects of human bile and were con-
sistent with the relative growth data in porcine and
human bile.
Outer membrane stability
Dihydropicolinate reductase (DapB) catalyzes the fourth
step in the biosynthesis of meso-diaminopimelate, an
essential intermediate for the synthesis of bacterial pep-
tidoglycan. The up-regulation of this enzyme suggested
the triggering of enhanced repair of damaged cell-wall
components by the bacterium in response to porcine
bile. This is consistent with the up-regulation also of 2-
isopropylmalate synthase, an enzyme involved in the
synthesis of hydrophobic amino acids [36] required for
the repair of damaged membrane components and stabi-
lization of protein-membrane associations. In response
to human bile, ketol-acid reductoisomerase, involved in
the synthesis of hydrophobic amino acids [36], and the
cell shape protein, MreB involved in the co-ordination
of cell morphogenesis [37] were up-regulated. DapB,
dDTP-glucose dehydratase and UDP-glucose 6-dehydro-
genase will result in decreased synthesis of peptidogly-
can as well as dTDP glucose and UDP-D glucuronate,
the down-regulation of these enzymes would result in
lower levels of these sugars used in cell wall biosynthesis
[38] and may compromise the membrane stability of the
bacterium. These molecular events would be reflected in
a greater susceptibility of H. hepaticus to human bile
than to porcine bile.
Glycine biosynthesis
A physiological role of glycine hydroxymethyltransferase
(GlyA) is the reversible interconversion of serine and
glycine. It plays a major role in the generation of folate
coenzymes, which provide one-carbon units for the
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ubiquinone, and methionine [39]. Thus, the down-regu-
lation of GlyA in the presence of human bile and its up-
regulation in the presence of porcine bile will affect dif-
ferently the biosynthesis of these metabolic products by
the bacterium in the presence of the two types of bile.
Interestingly, phosphoglycerate dehydrogenase (SerA)
that catalyzes the conversion of serine to glycerate
which eventually enters the glyoxylate pathway was
down-regulated by H. hepaticus g r o w ni np o r c i n eb i l e
and not regulated by human bile. A tendency to con-
serve serine is a possible strategy to ensure sufficient
supply of this amino acid for the synthesis of glycine.
Motility
Up-regulation by H. hepaticus of the flagellar proteins
FlaAB in the presence of human or porcine bile would
increase its motility in growth media containing either
type of bile. The statistically significant up-regulation (p
<0 . 0 5 )o ft h eflaAB transcripts measured in bacterial
cells grown in either type of bile confirmed the observa-
tion with the flagellar proteins (Figure 4), and thus
served as an internal validation for the proteomic data.
It correlated also with the observed speeds of the bac-
terium in 0.05% and 0.01% human and porcine bile,
respectively, which move significantly greater than in
the absence of bile (p < 0.01); there was no difference in
the percentage of motile cells between the 0.01% and
0.05% human and porcine bile, respectively. Bacterial
flagella contain a specialized secretion apparatus that
functions to deliver the protein subunits that form the
filament and other structures outside the membrane; the
flagellar assembly protein FliH regulates the flagellar
ATPase FliI activity, preventing non-productive ATP
hydrolysis, and also acts to target FliI to the C ring
complex of the flagellar basal body [40]. Low ATP levels
in H. hepaticus grown in the presence of human bile
could make the regulatory action of FliH on FliI less
important and lead to a decrease in the expression of
FliH. As a consequence, the contribution of this protein
to the export of FliI will be diminished too. This would
not necessarily compromise the export of the flagellar
apparatus, since H. hepaticus flagellar secretion may
require a proton motive force and not ATP hydrolysis
by FliI as in the case of Salmonella enterica [41]. Down-
regulation of the two-component system response regu-
lator OmpR is consistent with the repellant effect of bile
on H. hepaticus. This agrees with the report that human
bile as well as taurocholic and taurodeoxycholic acids
(the predominant bile acids found in porcine bile)
exerted chemorepellant effects on H. pylori [42].
Virulence and colonization
Cytolethal distending toxin Cdt and urease are impor-
tant factors in H. hepaticus cytotoxicity, colonization
and virulence. Cdt is essential for persistent infection of
the gastrointestinal tract and increases the severity of
mucosal inflammation or liver disease in susceptible
mouse strains [43]. The protein is composed of three
subunits: the catalytic subunit CdtB has DNase 1-like
activity and targets eukaryotic DNA, and CdtAC are
binding proteins for delivering CdtB into target cells.
Mutations in CdtABC that cause any of the three subu-
nits to lose function prevent the bacterial cell from
inducing cytotoxicity [44]. Urease supports H. pylori
colonization of the stomach by increasing the pH of the
bacterial microenvironment through the hydrolysis of
urea [45]. Urease levels of expression in H. hepaticus are
lower than in H. pylori, but relatively high compared
with those of many other ureolytic pathogens. Cytolethal
distending toxin subunit C (CdtC) and urease subunit A
(UreA) were down-regulated by human and porcine
bile, respectively. The correlation of these results with
the down-regulation of the expressions of ureA in the
presence of porcine bile as well as of cdtBC in the pre-
sence of human and porcine bile, although only small
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Figure 4 Differential expression of Helicobacter hepaticus
virulence, colonization and oxidative stress genes in [A] 0.05%
human bile, and [B] 0.1% porcine bile. 16 S rDNA was used as
internal control to normalize the relative expressions of the genes.
H. hepaticus specific primer set used for the qRT-PCR has been
published previously [17] Experiments were performed in triplicate.
Data and standard errors are from two independent experiments.
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and for cdtC in both bile types (Figure 4), served to vali-
date the proteomic data. In porcine bile the bacterium
also down-regulated the expression levels of ureB and
cdtB, and in human bile ureAB were down-regulated as
well. It is noteworthy that in bovine bile H. hepaticus
also down-regulated CdtC and UreAB [17] indicating
that the presence of bile did not increase the pathogeni-
city of H. hepaticus dependent on these factors.
Thus, the results showed that at the physiologically
neutral environment of H. hepaticus bacterial cultures,
the presence of bile down-regulated the expression of
ureAB, and attenuated the pathogenicity of the bacter-
ium dependent on CdtBC. Down-regulation of virulence
factors by bile have been reported also in other bacteria
[46,47]. For example, in the presence of bile the expres-
sion of the Salmonella invasion protein and the Type III
secretion proteins are down-regulated; [46] in Vibrio
cholerae, the production of cholera-toxin and toxin-
regulated pilus are significantly down-regulated; [47]
and in C. jejuni, GalU is down-regulated [24].
Transcriptional regulation of virulence, colonization and
oxidative stress-related genes by H. hepaticus in response
to bile
Together with the down-regulation of the expressions of
cdtBC and ureAB in the presence of human and porcine
bile, the transcript levels of other virulence genes of H.
hepaticus such as mviN, and vacB were also down-regu-
lated in cells exposed to both types of bile, although
only a small down-regulation was measured in the case
of mviN for cells exposed to human bile (Figure 4). On
the other hand, colonization genes of H. hepaticus,
namely flaAB and galU, were up-regulated in both types
of bile. The gene pldA encoding a phospholipase was
significantly up-regulated in human bile but not in por-
cine bile, while mreB showed significant down-regula-
tion only in porcine bile. H. hepaticus in response to
human bile down-regulated the oxidative stress response
genes kat, mda, sodF and tsa, while the bacterium up-
regulated same genes in porcine bile with the exception
of kat (Figure 4). In the human bile, down-regulation of
sodF mRNA transcript was in agreement with its down-
regulation at the proteome level. Similarly, up-regulation
of tsa in porcine bile corresponded with the protein up-
regulation, however, the up-regulation of sodF transcript
in the same bile, albeit a non-significant up-regulation
(P > 0.05), did not correspond with the down-regulation
of the protein. Incongruence between parallel transcrip-
tomic and proteomic experiments has also been
reported by others [48,49]. The level of any protein will
be the balance between its rate of synthesis and its rate
of degradation; thus, a decrease in the level of a protein
could be the result of decreased synthesis or enhanced
degradation. Since the transcriptional up-regulation of
sodF in porcine bile could not explain the down-regula-
tion of the protein, it could be hypothesized that
decreased turnover rate was responsible for the observed
SodF level [50].
Owing to their importance in survival and pathogen-
esis, the transcriptional regulation of the genes pre-
sented in Figure 4 has been investigated in the response
to bile of other enteric pathogenic bacteria [51]. The
MivN homolog (HH0516) is required by S. typhimur-
ium, E. coli and Burkhoderia pseudomallei for virulence
[52]; the gene hh0516 encodes a homologue of the
mouse virulence factor of these bacteria. In B. pseudo-
mallei,e x p r e s s i o no fmivN is influenced by free-iron
availability in the media and by the growth phase [52].
The down-regulation of mivN by H. hepaticus suggested
reduced intracellular free iron concentration, which
could result from iron chelation by bile components
[53]. The vacuolating cytotoxin B VacB, is required for
H. hepaticus virulence as well as in Shigella and enter-
oinvasive E. coli [54]; vacB was down-regulated in the
presence of either type of bile. The down-regulation of
these genes suggests that bile is not an environmental
cue required for H. hepaticus virulence.
Up-regulation of the transcript levels of H. hepaticus
colonization genes flaAB, galU and pldA suggested that
bile can aid in bacterial colonization of its specific
niches in the host. Up-regulated flaAB would help H.
hepaticus to move away from bile as discussed pre-
viously, but it also can assist the bacterium to reach its
niches. Up-regulation of the phospholipase encoded by
pldA in the presence of bile suggested that like in H.
pylori where the gene aids the bacterium to colonize the
g a s t r i cm u c o s a[ 5 5 ] ,P l d Am a yb eac o l o n i z a t i o nf a c t o r
in H. hepaticus stimulated by bile. Similarly to Strepto-
coccus pneumoniae and V. cholerae where galU mutants
showed reduced ability to colonize the mouse small
intestine [56], up-regulation of galU by H. hepaticus in
t h ep r e s e n c eo fe i t h e rt y p eo fb i l ew o u l ds u g g e s tt h a ti t
acts also as a colonization factor activated by bile; it is
noteworthy that in H. hepaticus response to bovine bile
[17], elevated level of GalU was also measured. The up-
regulation of the oxidative stress response genes in por-
cine bile but not in human bile underscores the differ-
ence in the pattern of H. hepaticus stress responses
induced by the presence of human or porcine bile as
discussed previously.
Conclusion
The protein and gene regulations of H. hepaticus in
response to human and porcine bile observed in this
study, as well as to bovine bile [17], provided molecular
explanations for the observed susceptibility of the bac-
terium to the three types of bile (Figure 1) and [17]. H.
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bile as well as on bile concentration; in this study the
bacterium was found to be more susceptible to human
bile than porcine bile. To combat oxidative stress
induced by the different bile acids present in human or
porcine bile, H. hepaticus employed different mechan-
isms involving modulation of metabolic processes and
energy balance. Overall, this ability was more impaired
in human bile than in porcine bile; extrusion of bile
acids and maintenance of membrane homeostasis in the
bacterium appeared to be more compromised in human
bile than porcine bile. The expression and/or activities
of several proteins involved in virulence, colonization,
genetic and physiological interactions of H. hepaticus
with bile were modulated differently by the bacterium in
response to human or porcine bile revealing that bile
can be an important factor that determines host adapta-
tion, localization and colonization of specific niches
within the host environment.
Materials and methods
Bile extracts
Dried unfractionated porcine bile (Sigma, North Ryde,
N S W ,A u s t r a l i a )w a sd i s s o l v e di nB r a i nH e a r tI n f u s i o n
(BHI) broth (Oxoid, Heidelbeg, VIC, Australia) to the
appropriate concentrations and filter-sterilized using
0.22 μm filters (Millipore, Kilsyth, Camperdown, VIC,
Australia). Human bile was collected from patients at
Royal Prince Alfred Hospital, NSW, Australia. The col-
lection was performed under the ethics approval proto-
col number X05-0343 of 30 May, 2006 titled “Molecular
and cellular pathogenesis of human liver disease”
granted by the Human Research Ethics Committee
(HRECS) of Australia. Bile from different patients were
pooled and boiled under atmospheric pressure for 1 h,
and vacuum dried for 48 h. The dried bile was then dis-
solved in BHI broth (Oxoid, Australia) to the appropri-
ate concentrations and filter-sterilized.
Bacterial strain and growth conditions
Helicobacter hepaticus strain ATCC 51449 was cultivated
in Campylobacter Selective Agar (CSA), consisting of
Blood Agar Base No. 2 (Oxoid, Australia), and supplemen-
ted with 5% (v/v) defibrinated horse blood (Oxoid, Austra-
lia). The media contained 2 μg/ml fungizone (Bristol-
Myers Squibb, Sydney, NSW, Australia), 0.32 μg/ml poly-
mixin B, 5 μg/ml trimethoprim, and 10 μg/ml vancomycin
(Sigma, Australia). Cultures were incubated for 48 h at 37°
C under the microaerobic conditions of 5% CO2,5 %O 2
and 90% N2. Bacteria were harvested from plates, washed
in BHI broth, resuspended to a density of OD600 ~0.1. Cell
purity was checked by inspecting the characteristics of
bacterial colonies on CSA plates and the morphology of
bacteria under phase-contrast microsopy. The responses
of H. hepaticus to human or porcine bile were determined
by inoculating bacterial cells at a density of ca.1 0
4 cfu/mL
into 2 mL of BHI broth containing 0-0.5% human or por-
cine bile concentrations in a 24-well microtitre plate. To
determine the specific effects of each bile on H. hepaticus,
bacterial growth was determined as a function of time for
various concentrations of human and porcine bile.
Bacterial motility and morphology in cultures with human
or porcine bile
H. hepaticus motility and morphological characteristics
were determined employing a previously described
method [17]. Briefly, at 48 h the percentage of motile
bacillar-shaped cells in cultures with 0%, 0.05% and 0.1%,
human or porcine bile was evaluated on a scale from 0%
(no motile cells) to 100% (all cells in motion). The average
time taken by 10 cells to move across the microscope field
was recorded and used to compute the average speed of
the bacterium. Changes in morphology of H. hepaticus in
human and porcine bile were observed by phase-contrast
microscopy. The percentage of coccoid forms at 48 h in 0-
0.5% human or porcine bile at 48 h was estimated by eval-
uating the number of nonbacillar forms per field in three
independent samples of each culture.
Preparation of cell-free protein extracts
For protein expression studies, cells harvested at exponen-
tial growth phase in control cultures or in the presence of
0.05% or 0.1% (w/v) human and porcine bile, respectively
were treated with chloramphenicol (128 mg/ml) to termi-
nate protein synthesis. Bacteria in triplicate cultures from
at least two independent experiments were centrifuged at
5000 × g at 4 C for 25 min, and the cell pellets were resus-
pended and washed twice with 0.2 M ice-cold sucrose.
The bacteria were then disrupted by thrice freezing and
thawing, and the lysate was suspended in 0.5 ml of Tris-
SDS-Urea buffer [50 mM Tris, pH 8.0; 0.1% sodium dode-
cyl sulphate (SDS); 2.5 M urea]. Cell debris was removed
by centrifugation at 14000 × g at 4 C for 20 min, and cell-
free extracts used for 2-dimensional gel electrophoresis.
The protein content of cell-free extracts was estimated by
the bicinchoninic acid assay employing a microtitre proto-
col (Pierce, Rockford, IL, USA); optical densities were
measured at 595 nm using a Beckman Du 7500 spectro-
photometer to measure the absorbances of the copper
complexes in both samples and standards. The protein
concentration of each sample was calculated based on a
calibration curve constructed with known concentrations
of bovine serum albumin (Sigma, Australia).
Two-dimensional polyacrylamide gel electrophoresis and
image analysis
Two-dimensional polyacrylamide gel electrophoresis
(2D-PAGE) was performed as described previously
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ent (IPG) strip (Amersham Biosciences, Melbourne,
VIC, Australia) was rehydrated overnight with 500 μlo f
isoelectric focusing rehydration buffer that contained
150 μg of the protein extract, 8 M urea, 100 mM dithio-
threitol (DTT), 40 mM Tris-HCl pH 8.8, 2% IPG buffer,
65 mM 3-[(3-cholamidopropyl)-dimethylammonio]-1-
propanesulfonate and 2% nuclease buffer. Isoelectric
focusing was conducted using the Multiphor II system
(Amersham Biosciences, Australia) at a maximum of
3500 V for 21 h until a total of 65 500 V-hour were
achieved. For the second dimension, strips were equili-
brated by rocking in two buffers containing 6 M urea,
20% (v/v) glycerol, 2% (w/v) SDS, 375 mM Tris-HCl;
the first buffer with 130 mM DTT, and the second with
135 mM iodoacetamide (IA). Sodium dodecyl sulphate-
polyacrylamide gel electrophoresis (SDS-PAGE) was per-
formed on 11.5% acrylamide gels using a Protean II sys-
t e m( B i o - R a d ;R e g e n t sP a r k ,N S W ,A u s t r a l i a )a t5 0V
for 1 h, followed by 64 mA for 5 h or until the bromo-
phenol blue dye front reached the bottom of the gels.
The gels were fixed individually in 200 ml of fixing solu-
tion 50% (v/v) methanol, 10% (v/v) acetic acid with gen-
tle rocking for a minimum of 0.5 h, stained employing a
silver staining method [57], and imaged using a Umax
PowerLook-1000 flatbed scanner (FujiFilm; Tokyo,
Japan). For comparative gel-image analysis, statistical
data were acquired and analyzed using the Z3 software
package (Compugen; Jamesburg, NJ, USA). For analyses,
one gel from cells grown in the absence of bile served
as the reference gel; master gels were compiled from the
three gels from each growth condition, and were com-
pared to determine the relative intensities of each pro-
tein spot. Statistical analyses (Student t-test, 95%
confidence interval) were performed on three gels from
each growth condition to determine the differential spot
intensities between control and test conditions.
Identification of proteins
Protein spots showing 2-fold or more differences in
intensity between both experimental conditions were
identified by liquid chromatography-tandem mass spec-
trometry (LC-MS/MS) as described before [17]. Briefly,
spots were excised from the gels and washed twice for
1 0m i ni n2 0 0μlo f1 0 0m MN H 4HCO3, reduced at 37°
Cf o r1hw i t h5 0μlo f1 0m MD T T ,a l k y l a t e df o r1h
in 50 μl of 10 mM IA, washed for 10 min with 200 μlo f
10 mM NH4HCO3, dehydrated in acetonitrile, and tryp-
sin-digested with 10 ng/μl of trypsin (Promega, Annan-
dale, NSW, Australia). After digestion for 14 h at 37°C,
peptides were extracted by washing the gel slice for 15
min with 25 μl 1% formic acid, followed by dehydration
in acetonitrile. Digests were then dried in vacuo,r e s u s -
pended in 10 μl 1% formic acid and submitted for
Quadrupole-TOF (Q-TOF) analysis on a Micromass
instrument which generated CID as previously described
[17]. Database searches with Mascot search engine
(Matrix Science Ltd.; Boston, MA) was performed as
previously described [14,15]. Proteins were identified
with high confidence according to a matching score >
49 with more than 2 assigned peptides both correspond-
ing to P < 0.05. All searches were performed on the
National Center for Biotechnology Information non-
redundant (NCBI nr) database.
RNA extraction and cDNA synthesis
Total RNA was extracted from bacterial cells suspended
in liquid cultures with RNA-protect using the Qiagen
method according to the manufacturer’si n s t r u c t i o n s
(Qiagen Pty. Ltd.; Doncaster, VIC, Australia) as pre-
viously described [17]. RNA samples were stored at -80°
C until used. Total RNA was reverse-transcribed to
cDNA using the SuperScript III reverse transcriptase
following the manufacturer’s instructions (Invitrogen;
Mulgrave, Victoria, Australia).
Real Time RT-PCR
To serve as validation for the proteomic data as well as
provide insight into the regulation by H. hepaticus of
virulence, colonization and oxidative stress genes, the
effects of human and porcine bile on the transcriptional
regulation of selected 19 genes related to virulence,
colonization and oxidative stress response were studied.
Four independent real-time quantitative PCR experi-
ments were carried out. The analysis of each gene was
performed in triplicate for each experiment in a Corbett
Research Rotor Gene RG-3000 thermal cycler (Corbett
Life Science; Sydney, NSW, Australia), using the SYBR
GreenER qPCR Universal Supermix according to the
manufacturer’s instructions (Invitrogen, Australia). Each
reaction was performed in an individual tube in a 72
tube strip, containing 12.5 μlS u p e r m i x ,1 . 0μl of 100
ng/μl forward primer, 1.0 μl of 100 ng/μl reverse primer,
1.0 μl of 200 ng/μl cDNA, and diethylpyrocarbonate-
treated water to a total volume of 25 μl. As controls,
reactions were run for each set in the absence of tem-
plate cDNA to detect any contamination. Conditions for
the qRT-PCR were as described previously [17]. The
relative expression of each target gene was normalized
to the 16 S rDNA gene using the method described by
Pfaffl et al. [58] employing the expression:
Ratio = (ETarget) CtTarget(Control−Sample)/(EReference) CtReference(Control−Sample).
The amplification efficiencies of target and reference
genes, E was assumed in this study to be 2 for all genes
[59], and Ct is the comparative threshold cycle. The
control/sample values were obtained with template
Okoli et al. Proteome Science 2012, 10:27
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Page 14 of 16cDNA from H. hepaticus cells exposed to human bile (0
and 0.05%), and porcine bile (0 and 0.1%). H. hepaticus
specific primer set used for the qRT-PCR has been pub-
lished previously [17].
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